{"date": "2021-07-30 06:11:05.162000+00:00", "ticker": "AVV", "mrkt_info": {"open": 3936.0, "close": 3928.0}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-lead\">\n<p>RNS Number : 9731GAVEVA Group PLC30 July 2021</p>\n</div>\n<div class=\"tr-npp-body\">\n<p>\n<span>AVEVA GROUP PLC</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>Q1 Trading Update</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>AVEVA Group plc ('AVEVA' or 'the Group') announces the following trading update for the period from 1 April 2021 to 30 June 2021.</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>AVEVA has had a good start to FY22, achieving approximately 11% revenue growth in the first three months of the financial year on a pro forma organic constant currency basis <span>(1)</span> .</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>All of the Group's revenue lines grew, with Subscription growing in line with overall Group revenue and Perpetual licences increasing significantly.</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>AVEVA will report half year results for the financial period</span>\n<span>from 1 April 2021 to 30 September 2021 on 9 November 2021.</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n<span>\n<span>(1)</span>\n</span>\n</span>\n<span>Pro forma organic constant currency revenue growth includes both AVEVA and OSIsoft in the prior year comparator and is adjusted for foreign exchange translation movements, disposals and the impact of the deferred revenue haircut under IFRS 3 (Business Combinations).</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>\n</span></p>\n<p>\n<span>Enquiries:</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>AVEVA Group plc</span>\n</p>\n<p>\n<span>Matthew Springett, Head of Investor Relations: +44 (0) 7789 818 684</span>\n</p>\n<p>\n<span>\n</span></p>\n<p>\n<span>FTI Consulting LLP</span>\n</p>\n<p>\n<span>Edward Bridges / Dwight Burden: +44 (0) 203 727 1000</span>\n</p>\n<p>This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact <a href=\"mailto:rns@lseg.com\" data-type=\"email\" translate=\"no\">rns@lseg.com</a> or visit <a href=\"http://www.rns.com/\" data-type=\"url\" class=\"tr-link\" translate=\"no\">www.rns.com</a> .RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our <a href=\"https://www.lseg.com/privacy-and-cookie-policy\" data-type=\"url\" class=\"tr-link\" translate=\"no\">Privacy Policy</a> .END</p>\n<p>TSTDKCBNPBKDPOB</p>\n</div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright (c) 2021 Thomson Reuters Limited.</p></div>"}